According to the latest study from BCC Research, the "Cancer Immunotherapy: Technologies and Global Markets" is expected to grow from ...

Global immunotherapy drugs market is valued at approximately USD 247.44 billion in 2023 and is projected to grow at a healthy CAGR of 15.3% over the forecast period 2024-2032. Request To Download Free ...

Shares of CEL-SCI Corporation (NYSE:CVM) surged 25% following the announcement of a new partnership with a prominent Saudi ...

According to CEL-SCI, the SFDA typically responds to Breakthrough Medicine Designation applications within approximately 60 days. The company stated that several Saudi funds have expressed interest in ...

The hunt for a medical breakthrough has been caught up in the Trump administration's political assault on the university.

Immune checkpoint inhibitors (ICIs) are revolutionizing cancer treatment by helping the immune system better find and attack ...

Personalis and Tempus AI are adding colorectal cancer as a new indication to their existing commercialization agreement.

Cancer survivors who received high-cost immunotherapies appear more likely to experience financial hardship, according to ...

NASHVILLE, Tenn. (WTVF) — June is Cancer Immunotherapy Month. Immunotherapy drugs have been on the market for more than a ...

The story behind the development of immune checkpoint inhibitors, fulfilling the promise of cancer immunotherapy ...